TrialCancer medicine2019

Phase I trial of TAK-385 in hormone treatment-naïve Japanese patients with nonmetastatic prostate cancer.

Hiroyoshi Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.